Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bio Food & Development Co. Ltd. (251120:KRX), powered by AI.
Bio Food & Development Co. Ltd. is currently trading at ₩9,310. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bio Food & Development Co. Ltd. on Alpha Lenz.
Bio Food & Development Co. Ltd.'s P/E ratio is 12.1.
“Bio Food & Development Co. Ltd. trades at a P/E of 12.1 (undervalued) with solid ROE of 10.0%. Operating margin of 32.6% indicates strong profitability.”
Ask for details →Bio Food & Development Co. Ltd. is a prominent entity in the food and agriculture sector, specializing in the development and production of eco-friendly and sustainable food products. This company aims to address the increasing global demand for healthy and organic food options by utilizing advanced agricultural techniques and biotechnology. Bio Food & Development Co. Ltd. is known for its innovation in food science and commitment to sustainability, often leading the way in producing GMO-free products. The company has a significant impact on the agriculture industry by promoting sustainable farming practices and reducing the carbon footprint associated with food production. In the financial market, Bio Food & Development Co. Ltd. plays a vital role by providing investors with an opportunity to participate in the growing market of eco-friendly and health-oriented food products, appealing to a broad range of socially conscious consumers and businesses alike. As consumer awareness around health and environmental issues continues to rise, the company's focus on maintaining high standards of food safety and environmental responsibility highlights its importance in the global market.
“Bio Food & Development Co. Ltd. trades at a P/E of 12.1 (undervalued) with solid ROE of 10.0%. Operating margin of 32.6% indicates strong profitability.”
Ask for details →Bio Food & Development Co. Ltd. (ticker: 251120) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $81.0B.
The current price is ₩9,310 with a P/E ratio of 12.14x and P/B of 1.16x.
ROE is 10.03% and operating margin is 32.60%. Annual revenue is $19.2B.